Hess, P. L., Kennedy, K., Cowherd, M., Virani, S. S., Masoudi, F. A., Navar, A. M., . . . Maddox, T. M. (2017). Implications of the FDA approval of PCSK9 Inhibitors and FOURIER Results for Contemporary Cardiovascular Practice: An NCDR(®) Research to Practice (R2P) Project. Am Heart J.

Hess, Paul L., Kevin Kennedy, Michael Cowherd, Salim S. Virani, Frederick A. Masoudi, Ann Marie Navar, Robert W. Yeh, P. Michael Ho, and Thomas M. Maddox. "Implications of the FDA Approval of PCSK9 Inhibitors and FOURIER Results for Contemporary Cardiovascular Practice: An NCDR(®) Research to Practice (R2P) Project." Am Heart J 2017.

Hess, Paul L., et al. "Implications of the FDA Approval of PCSK9 Inhibitors and FOURIER Results for Contemporary Cardiovascular Practice: An NCDR(®) Research to Practice (R2P) Project." Am Heart J 2017.